Lipopolysaccharide-enhanced early proliferation of insulin secreting NIT-1 cell is associated with nuclear factor-kappaBmediated inhibition of caspase 3 cleavage

Chinese Medical Journal

Volumn 124, Issue 22, 2011, Pages 3652-3656

  Liu, Shan Ying ^a   Liang, Qi Jun ^a   Lin, Tian Xin ^a   Fan, Xin Lan ^a   Liang, Ying ^a   Heemann, Uwe ^b   Li, Yan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Caspase 3; Lipopolysaccharide; NIT 1 cell; Nuclear factor B; Toll like receptor 4

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ARTICLE; CELL COUNT; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; INCUBATION TIME; INSULIN RELEASE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN CLEAVAGE; RECEPTOR UPREGULATION;

ANIMALS; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; INSULIN; INSULINOMA; LIPOPOLYSACCHARIDES; MICE; NF-KAPPA B; TOLL-LIKE RECEPTOR 4;

EID: 82255173951     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.22.010     Document Type: Article

References (21)

1. Mehta NN, McGillicuddy FC, Anderson PD, Hinkle CC, Shah R, Pruscino L, et al. Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes 2010; 59: 172-181.
2. Creely SJ, McTernan PG, Kusminski CM, Fisher M, Da Silva NF, Khanolkar M, et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 2007; 292: E740-E747
3. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56: 1761-1772.
4. Song MJ, Kim KH, Yoon JM, Kim JB. Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem Biophys Res Commun 2006; 346: 739-745.
5. Dasu MR, Devaraj S, Park S, Jialal I. Increased toll-like receptor activation and TLR ligands in recently diagnosed type 2 diabetes subjects. Diabetes Care 2010; 33: 861-868
6. Kiely A, Robinson A, McClenaghan NH, Flatt PR, Newsholme P. Toll-like receptor agonist induced changes in clonal rat BRIN-BD11 beta-cell insulin secretion and signal transduction. J Endocrinol 2009; 202: 365-373.
7. Vives-Pi M, Somoza N, Fernández-Alvarez J, Vargas F, Caro P, Alba A, et al. Evidence of expression of endotoxin receptors CD14, toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet beta cells. Clin Exp Immunol 2003; 133: 208-218.
8. Doyle SL, O'Neill LA. Toll-like receptors: from the discovery of NF-kB to new insights into transcriptional regulations in innate immunity. Biochem Pharmacol 2006; 72: 1102-1113.
9. O'Neill LA, Bowie AG. The family of five. TIR-domaincontaining adaptors in Toll-like receptor signaling. Nat Rev Immunol 2007; 7: 353-364.
10. Liu S, Li Y, Liang Q, Gan X, Liang Y, Liang W, et al. Low dose LPS enhances proliferation of a mouse insulinoma cell line NIT-1. Chin Pharmacol Bull (Chin) 2009; 25: 1430-1433.
11. Wajchenberg BL. β-cell failure in diabetes and preservation by clinical treatment. Endocrine 2007; 28: 187-218
12. Porter AG, Jänicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ 1999; 6: 99-104.
13. Radziszewska A, Schroer SA, Choi D, Tajmir P, Radulovich N, Ho JC, et al. Absence of caspase-3 protects pancreatic {beta}-cells from c-Myc-induced apoptosis without leading to tumor formation. J Biol Chem 2009; 284: 10947-10956.
14. Yamada K, Ichikawa F, Ishiyama-Shigemoto S, Yuan X, Nonaka K. Essential role of caspase-3 in apoptosis of mouse beta-cells transfected with human Fas. Diabetes 1999; 48: 478-483.
15. Liadis N, Murakami K, Eweida M, Elford AR, Sheu L, Gaisano HY, et al. Caspase-3-dependent beta-cell apoptosis in the initiation of autoimmune diabetes mellitus. Mol Cell Biol 2005; 25: 3620-3629.
16. Melloul D. Role of NF-κB in β-cell death. Biochem Soc Trans 2008; 36: 334-339.
17. Miura K, Karasawa H, Sasaki I. cIAP2 as a therapeutic target in colorectal cancer and other malignancies. Expert Opin Ther Targets 2009;13: 1333-1345.
18. Hui H, Dotta F, Di Mario U, Perfetti R. Role of caspases in the regulation of apoptotic pancreatic islet beta-cells death. J Cell Physiol 2004; 200: 177-200.
19. LaCasse EC, Baird S, Korneluk RG, MacKenzie AE. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 1998; 17: 3247-3259.
20. Chu ZL, McKinsey TA, Liu L, Gentry JJ, Malim MH, Ballard DW. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proc Natl Acad Sci U S A 1997; 94: 10057-10062.
21. Stehlik C, de Martin R, Kumabashiri I, Schmid JA, Binder BR, Lipp J. Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J Exp Med 1988; 188: 211-216.